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ABSTRACTS 
ASSOCIATION B E T W E E N hRYR2 MUTATIONS W I T H V E N T R I C U L A R 
TACHYCARDIA IN K A Z A K H POPULATION 
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Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited 
disease characterized by polymorphic or bidirectional ventricular arrhythmias (VA) triggered by 
physical or emotional stress in young people with a structurally normal heart. 
Materials and methods: Patients with arrhythmia - ventricular tachycardia were involved 
into research. Diagnosis was verified in National Research Cardiac Surgery Center, Astana. Target 
areas of hRYR2 gene including the most important 45 exons were amplified with PCR and directly 
sequenced. 
Results: Genetic variants of hRYR2 gene in two catecholaminergic polymorphic ventricular 
tachycardia (CPVT) patients and 14 ventricular tachycardia (VT) patients were screened. Total 
number of VT patients whose mutation in hRYR2 gene screened was 35 people. Also genetic 
analysis was carried out for relatives of patient who had been observed to carry mutation in hRYR2 
gene. New mutations in CPVT patients (c.A13892T; p.D4631V) and new mutation in one VT 
patient (c. G5428C;p.V1810L) was detected. Both variants are located in phylogenic conservative 
areas of hRYR2 gene and seems to be pathological according to MutationTaster and PolyPhenII 
prediction programs. Also three well-known synonymous polymorphisms rs3765097, rs2253273 
and TMPESP 1237 664 067 in studied group were detected. Moreover mutation (c.C7511T; 
p.T2504M) was found which previously was detected in arrhythmogenic right ventricular dysplasia 
patient. This variant is located in phylogenic conservative areas of hRYR2 gene and assessed as 
pathological (points by MutationTcister D (0.99) and by PolyPhenllD (0.99)). 
Conclusion. This research is useful to evaluate necessity of genetic screening and reliable 
genetic consultation for ventricular rhythm disorder patients in order to predict and prevent sudden 
cardiac death. 
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